Subscribe To

Price Alert Latest News Economic Calendar News

SSKN / STRATA Skin Sciences to Participate in the Lytham Partners Spring 2022 Investor Conference

HORSHAM, Pa., March 28, 2022 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, announced today that it will be participating in the Lytham Partners Spring 2022 Investor Conference taking place virtually on April 4-7, 2022. Read More

Demo Live Account See Partner Details

Content Topics

Strata

Skin

Sciences

Participate

Lytham

Partners

Spring

2022

Investor

Conference

Stock

SSKN

Posted: Mar 28 2022, 16:07

Author Name: GlobeNewsWire

SSKN News

By Seeking Alpha
August 9, 2023

STRATA Skin Sciences, Inc. (SSKN) Q2 2023 Earnings Call Transcript

STRATA Skin Sciences, Inc. (NASDAQ:SSKN ) Q2 2023 Earnings Conference Call August 9, 2023 4:30 PM ET Company Participants Nicole Jones - IR Bob Moccia

By Seeking Alpha
May 15, 2023

STRATA Skin Sciences, Inc. (SSKN) Q1 2023 Earnings Call Transcript

STRATA Skin Sciences, Inc. (NASDAQ:SSKN ) Q1 2023 Results Conference Call May 15, 2023 4:30 PM ET Company Participants Bob Moccia - Chief Executive Of

By Seeking Alpha
April 1, 2023

STRATA Skin Sciences, Inc. (SSKN) Q4 2022 Earnings Call Transcript

STRATA Skin Sciences, Inc. (NASDAQ:SSKN ) Q4 2022 Earnings Conference Call March 31, 2023 8:30 AM ET Company Participants Bob Moccia - CEO Chris Lesov

By GlobeNewsWire
March 28, 2023

STRATA Skin Sciences Reschedules Fourth Quarter 2022 Conference Call and Webcast to Friday, March 31, 2023

HORSHAM, Pa., March 28, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, comm

By GlobeNewsWire
March 14, 2023

STRATA Skin Sciences to Report Fourth Quarter 2022 Financial Results on March 28, 2023

HORSHAM, Pa., March 14, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, comm

By Zacks Investment Research
November 9, 2022

Strata Skin Sciences, Inc. (SSKN) Reports Q3 Loss, Tops Revenue Estimates

Strata Skin Sciences, Inc. (SSKN) delivered earnings and revenue surprises of 50% and 11.27%, respectively, for the quarter ended September 2022. Do t

By GlobeNewsWire
August 22, 2022

STRATA Skin Sciences to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase

HORSHAM, Pa., Aug. 22, 2022 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, comme

By Seeking Alpha
August 10, 2022

STRATA Skin Sciences, Inc.'s (SSKN) CEO Robert Moccia on Q2 2022 Results - Earnings Call Transcript

STRATA Skin Sciences, Inc. (NASDAQ:SSKN ) Q2 2022 Earnings Conference Call August 10, 2022 4:30 PM ET Company Participants Leigh Salvo - Investor Rela

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.